1.
The Present Treatment and Thinking of Anthracycline-resistant Metastatic Breast Cancer
蒽环类耐药转移性乳腺癌的治疗现状与思考
2.
An analysis on clinical efficacy of vinorelbine combined with gemcitabine for patients with anthracycline-and taxane-refractory metastatic breast cancer
长春瑞滨联合吉西他滨治疗蒽环类和紫杉类药物耐药的转移性乳腺癌的临床疗效分析
3.
Efficacy and Toxicity of Gemcitabine in Combination with Vinorelbine on Metastatic Breast Cancer;
吉西他滨联合长春瑞滨治疗蒽环类和紫杉类耐药的转移性乳腺癌的疗效和安全性评价
4.
Clinical Comparison of Gemcitabine Combined Cisplatin Regimen Versus Vinorelbine Combined Cisplatin Regimen as Chemotherapy for Anthracycline-and Taxane-resistant Metastatic Breast Cancer
GP与NP方案治疗对蒽环类及紫杉类均耐药的转移性乳腺癌的疗效观察
5.
Gemcitabine and cisplatin combination chemotherapy as alternative agents for metastatic breast cancer patients with anthracycline and taxane resistance
吉西他滨联合顺铂治疗蒽环类及紫杉类耐药转移性乳腺癌的临床观察
6.
Docetaxel and Xeloda Combined Chemotherapy in Anthracyclines Resistant Advanced Breast Cancer
多西他赛联合希罗达治疗蒽环类耐药性晚期乳腺癌
7.
Combination of Gemcitabine and Vinorelbine in the Treatment for 24 Cases of Advanced Breast Cancer with Taxanes/Anthracyclines Resistance
吉西他滨联合长春瑞滨治疗蒽环类/紫杉类耐药晚期乳腺癌24例
8.
Mitomycin Combined with Cisplatin in the Treatment of 23 Cases with Anthracycline and Taxane-Resistant Advanced Breast Cancer
丝裂霉素联合顺铂治疗蒽环类及紫杉类耐药晚期乳腺癌23例
9.
Clinical Observation on Gemcitabine Combined with Capecitabine in the Treatment of Anthracyclines-Resistant Breast Cancer
吉西他滨联合卡培他滨治疗蒽环类耐药的晚期乳腺癌的临床观察
10.
Paclitexal-based combination chemotherapy in the treatment of fourty-six patients with anthracycline-resistant advanced breast cancer
紫杉醇为主的联合方案治疗蒽环类耐药的晚期乳腺癌46例
11.
Preliminary observation of pemetrexed combined with cisplatin in the treatment after the treatment failure of anthracycline and taxane in advanced metastatic breast cancer
培美曲塞联合顺铂方案治疗蒽环类及紫杉类治疗失败的晚期转移性乳腺癌的初步研究
12.
Clinical Study of Echocardiography in Assessment of Cardiotoxity in Breast Cancer Patients Treated with Anthracycline;
超声心动图评价蒽环类药对乳腺癌患者心脏毒性的临床研究
13.
Relation of expression of survivin and BCRP gene in prediction of response to chemotherapy in metastatic breast cancer
生存素和乳腺癌耐药蛋白表达与转移性乳腺癌化疗效应的相关性
14.
Predictive Value of FHL1 in Breast Cancer Neoadjuvant Docetaxel and Anthracycline Chemotherapy
FHL1在乳腺癌紫杉联合蒽环类药物新辅助化疗中的预测价值
15.
Comparative Study of the Combined Chemotherapy with Paclitaxel or Antracycline for Advanced Breast Cancer
紫杉醇及蒽环类药物联合化疗治疗晚期乳腺癌的临床观察
16.
The Clinical Efficacy of DDP, MIT and CTX on the Treatment of Pleura Metastasis of Breast Cancer
顺铂、米托蒽醌及环磷酰胺联合治疗乳腺癌胸膜转移的临床疗效
17.
Gemcitabine plus cisplatin for the treatment of drug-resistant metastatic breast cancer
吉西他滨联合顺铂治疗耐药转移性乳腺癌的临床观察
18.
Gemcitabine Plus Cisplatin for Treatment of 34 Cases with Recurrent Breast Cancer after Anthracycines and/or Taxanes Chemotherapy
健择联合顺铂治疗蒽环类和(或)紫杉类化疗后复发性乳腺癌34例